Modern Alpha Content Hub Biden’s “Cancer Moonshot” Brings Biotech Focus Back to U.S. By Karrie GordonSeptember 15, 2022
ETF Building Blocks Content Hub Pfizer Vaccine Should Work Against Omicron, Just Less Efficiently By Karrie GordonNovember 30, 2021
Alternatives Content Hub Encouraging Election Year History for this Biotech ETF By Tom LydonSeptember 11, 2020
Nasdaq Investment Intelligence Content Hub New Biotech ETF Taps Into Small But Mighty Theme By Tom LydonAugust 6, 2020
ETF Building Blocks Content Hub When Innovation and Being Nimble Matters, Turn to this Biotech ETF By Tom LydonAugust 3, 2020
ETF Building Blocks Content Hub Fabulous Fundamentals Brighten Outlook for Healthcare, With This Biotech ETF By Tom LydonJuly 7, 2020
ETF Building Blocks Content Hub Another Round of Coronavirus Cases Puts This Biotech ETF in Focus By Tom LydonJune 29, 2020
Leveraged & Inverse Content Hub Consider These 2 Leveraged Biotech ETFs to Ride The M&A Trend By Ian YoungDecember 13, 2019
Thematic Investing Content Hub A Young Biotech ETF With Plenty of Potential By Todd ShriberSeptember 6, 2019
